Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Preventing breast and ovarian cancers in high-risk BRCA1 and BRCA2 mutation carriers.

The Medical journal of Australia - 18 Nov 2013

Collins Ian M, Milne Roger L, Weideman Prue C, McLachlan Sue-Anne, Friedlander Michael L, Hopper John L, Phillips Kelly-Anne

Abstract excerpt

OBJECTIVE: To estimate the prevalence of the use of cancer risk-reducing measures among Australian BRCA1 and BRCA2 mutation carriers. DESIGN, SETTING AND PARTICIPANTS: Prospective follow-up of female carriers of BRCA1 or BRCA2 mutations who had no personal history of cancer and were enrolled in a multiple-case breast cancer family cohort study (kConFab). Data, including cancer events and uptake of risk-reducing...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chemotherapy, Adjuvant
Share to Genes, BRCA2

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hereditary Breast and Ovarian Cancer Syndrome

Share to Mastectomy

Share to Ovariectomy

Share to Patient Acceptance of Health Care

Share to Salpingectomy

Share to Self Report

Source

Identifiers

PMID: 24237098
DOI: 10.5694/mja13.10848

Genes

BRCA1
BRCA2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Preventing breast and ovarian cancers in high-risk BRCA1 and BRCA2 mutation carriers.PMID 24237098Read ↗

Uptake of risk-reducing surgery in BRCA gene carriers in Wales, UK.Semantic proximity Read ↗

Risk-reducing surgery, screening and chemoprevention practices of BRCA1 and BRCA2 mutation carriers: a prospective cohort study.Semantic proximity Read ↗

Selected Medical Interventions in Women With a Deleterious Brca Mutation: A Population-Based Study in British ColumbiaSemantic proximity Read ↗

Attitude of BRCA1/2 mutation carriers towards surgical risk reduction for breast, ovarian and uterine cancer: still much to be done.Semantic proximity Read ↗

Cancer risk management in Tasmanian women with BRCA1 and BRCA2 mutations.Semantic proximity Read ↗

Risk reducing mastectomy in Norwegian BRCA1/2 carriers.Semantic proximity Read ↗

Risk-reducing surgery in women with familial susceptibility for breast and/or ovarian cancer.Semantic proximity Read ↗

Uptake of risk-reducing surgery in unaffected women at high risk of breast and ovarian cancer is risk, age, and time dependent.Semantic proximity Read ↗

Uptake of risk-reducing medical interventions among female BRCA1/2 pathogenic variant carriers: A population-based study in British Columbia.Semantic proximity Read ↗

Very high uptake of risk-reducing salpingo-oophorectomy in BRCA1/2 mutation carriers: A single-center experience.Semantic proximity Read ↗

Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality.Semantic proximity Read ↗

The clinical management of BRCA1 and BRCA2 mutation carriers.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.